Study finds association between atherosclerosis and changes in the structure, heart function

May 15, 2020

(Boston)--Even among individuals free of heart failure and myocardial infarction, there appears to be evidence of an association between calcium buildup in the coronary arteries (atherosclerosis) and changes in the structure and function of the heart.

Coronary artery calcium buildup or atherosclerosis is a strong predictor of future coronary heart disease. To date, the evidence suggests that coronary disease interacts and progresses along with the incipient development of myocardial disease, even in the absence of symptoms.

However, data on the association between coronary artery calcium and echocardiographic-based changes of the structure and function of the heart are lacking.

Researchers from Boston University School of Medicine (BUSM) evaluated the association between coronary artery calcification and echocardiographic measurements that quantify these changes in the heart among 2,650 participants (average age 51 years, 48 percent women) from the Framingham Heart Study. They observed that higher coronary artery calcium scores were associated with higher values of left ventricular mass index and aortic root diameter, consistent with potential adverse effects of changes in the size, shape, structure and function of the heart.

"We know that coronary artery disease progresses along with myocardial disease, but these findings suggest that there may be a direct link between coronary artery calcium and structural and functional changes in the heart, emphasizing the need to follow a healthy lifestyle in order to help prevent calcification of the arteries," explained corresponding author Vanessa Xanthakis, PhD, assistant professor of medicine and biostatistics at BUSM and an Investigator for the Framingham Heart Study.

Xanthakis believes additional studies are needed to further clarify the pathophysiological basis of the observed associations and to assess whether coronary artery calcium can be used to predict changes in the structure and function of the heart.

These findings appear online in PLOS ONE.
This study was partially funded by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contracts N01-HC-25195 and HHSN268201500001I) and by grants HL076784, G028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385, HL126136, 2R01HL092577, 1R01HL128914, 1P50HL120163, R01HL131532 (SC), R01HL134168 (SC); and 2-K24-HL04334. Cecilia Castro-Diehl was supported by the Multidisciplinary Training Program (T32) in Cardiovascular Epidemiology (5T32HL125232). Gary F. Mitchell was supported by Cardiovascular Engineering., Inc; this funder provided support in the form of salary for Gary F. Mitchell, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

Note to editors:

Susan Cheng has received consulting fees from Zogenix for work unrelated to this manuscript.Gary F. Mitchell has the following disclosures: a) grants: NIH, Novartis (both significant); b) consulting: Novartis, Servier (both significant); and c) ownership: Cardiovascular Engineering, Inc. (significant).

Boston University School of Medicine

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to